Pulmonary hypertension encompasses a range of conditions directly or indirectly leading to
elevated pressures within the pulmonary arteries. Five main groups of pulmonary …

Pediatric pulmonary hypertension is a complex disease with multiple, diverse etiologies
affecting the premature neonate to the young adult. Pediatric pulmonary arterial …

Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients
undergoing surgery and anesthesia. This document represents the first international …

Background: The arterial switch operation (ASO) is the gold standard operative correction of
neonates with transposition of the great arteries and intact ventricular septum, with excellent …

Background Cardiac catheterization is the gold standard for assessment and follow‐up of
patients with pulmonary hypertension (PH). To date, there are limited data about the factors …

Cardiac catheterization is important in the diagnosis and risk stratification of pulmonary
hypertensive vascular disease (PHVD) in children. Acute vasoreactivity testing provides key …

Pediatric pulmonary hypertension (PPH) is a multifactorial disease with diverse etiologies
and presenting features. Pulmonary hypertension (PH), defined as elevated pulmonary …

Objective To describe our experience with treprostinil, evaluate correlations with cardiac
function, and assess for adverse effects in neonates with congenital diaphragmatic hernia …

Abstract Background and aims The Tracking Outcomes and Practice in Pediatric Pulmonary
Hypertension (TOPP) registry is a global network established to gain insights into the …

Background The risks and benefits of pharmacologic treatment and operative closure of
patent ductus arteriosus (O-PDA) in premature infants remain controversial. Recent series …